Moderna, Inc.(MRNA)

$63.02—

Chart

Moderna, Inc.(MRNA)

NASDAQ

$63.02—

Chart Studio

MRNA(MRNA)

MRNA

Overview Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-1.38

Nov 5, 2026 · Reports before open

Revenue Estimate

$873M

FY2029E EPS$0.15

FY2030E EPS$2.51

Analyst Sentiment

Wall St. Consensus

Hold

25 analysts·High coverage

Score

7 Buy (28%)14 Hold (56%)4 Sell (16%)

Rating Breakdown

Strong Buy

00%

Buy

728%

Hold

1456%

Sell

416%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$25.00

-60.3%

Consensus

$45.00

-28.6%

Bull

$77.00

+22.2%

12-Month Target Range25 analysts

$25.00$45.00$77.00

Current $63.03Consensus

Current Price

$63.03

Above Consensus

$18.03

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+19.50%

EPS—

FY2028

Rev+29.62%

EPS—

FY2029

Rev+60.36%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$2.10B	$2.51B	$3.25B	$5.22B	$6.85B
Low	$1.97B	$2.12B	$2.17B	$4.28B	$5.62B
High	$2.16B	$3.11B	$7.29B	$7.72B	$10.14B
EBITDA Avg	$-500M	$-597M	$-774M	$-1.24B	$-1.63B
Low	$-514M	$-739M	$-1.73B	$-1.84B	$-2.41B
High	$-469M	$-504M	$-515M	$-1.02B	$-1.34B
EBIT Avg	$-551M	$-659M	$-854M	$-1.37B	$-1.80B
Low	$-567M	$-815M	$-1.91B	$-2.03B	$-2.66B
High	$-517M	$-556M	$-568M	$-1.12B	$-1.47B
Net Income Avg	$-3.43B	$-1.83B	$-1.22B	$60M	$975M
Low	$-3.72B	$-2.46B	$-1.80B	$46M	$748M
High	$-2.94B	$-34M	$264M	$97M	$1.58B
EPS Avg	$-8.72	$-4.79	$-2.86	$0.15	$2.51
Low	$-9.56	$-6.33	$-4.62	$0.12	$1.92
High	$-7.55	$-0.09	$0.68	$0.25	$4.07
Analysts (Rev / EPS)	16 / 16	16 / 15	16 / 14	14 / 7	14 / 11

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027
Revenue Avg	$863M	$696M	$264M	$120M	$1.10B	$986M
Low	$760M	$543M	$214M	$98M	$892M	$799M
High	$1.01B	$813M	$309M	$141M	$1.28B	$1.15B
EBITDA Avg	$-205M	$-165M	$-63M	$-29M	$-262M	$-234M
Low	$-240M	$-193M	$-73M	$-33M	$-305M	$-274M
High	$-181M	$-129M	$-51M	$-23M	$-212M	$-190M
EBIT Avg	$-226M	$-182M	$-69M	$-32M	$-289M	$-258M
Low	$-264M	$-213M	$-81M	$-37M	$-337M	$-302M
High	$-199M	$-142M	$-56M	$-26M	$-234M	$-210M
Net Income Avg	$-547M	$-738M	$-734M	$-838M	$-202M	$-374M
Low	$-761M	$-833M	$-894M	$-1.02B	$-246M	$-456M
High	$-368M	$-630M	$-553M	$-632M	$-152M	$-282M
EPS Avg	$-1.38	$-1.86	$-1.85	$-2.12	$-0.51	$-0.94
Low	$-1.92	$-2.10	$-2.26	$-2.58	$-0.62	$-1.15
High	$-0.93	$-1.59	$-1.40	$-1.59	$-0.38	$-0.71
Analysts (Rev / EPS)	9 / 9	9 / 9	7 / 6	4 / 3	4 / 3	7 / 6

Earnings Surprises

Recent Analyst Actions

Jul 21, 2026Goldman Sachs

Moderna price target raised to $67 from $49 at Goldman Sachs

Target:$67.00

+12.6%from $59.49

Jul 20, 2026Wolfe Research

Moderna (MRNA) PT Raised to $25 at Wolfe Research

Target:$25.00

-59.6%from $61.82

Jul 8, 2026Morgan Stanley

Moderna price target raised to $39 from $33 at Morgan Stanley

Target:$39.00

-51.1%from $79.77

Jul 7, 2026RBC Capital

Moderna price target raised to $45 from $38 at RBC Capital

Target:$45.00

-45.0%from $81.80

Jun 26, 2026Piper Sandler

Moderna price target raised to $77 from $69 at Piper Sandler

Target:$77.00

+13.8%from $67.66

May 4, 2026UBS

Moderna price target raised to $45 from $36 at UBS

Target:$45.00

-5.2%from $47.47

May 4, 2026RBC Capital

Moderna price target raised to $38 from $35 at RBC Capital

Target:$38.00

-18.9%from $46.87

May 1, 2026Goldman Sachs

Moderna price target raised to $49 from $43 at Goldman Sachs

Target:$49.00

+8.0%from $45.37

May 1, 2026Morgan Stanley

Moderna price target raised to $33 from $30 at Morgan Stanley

Target:$33.00

-25.3%from $44.18

Mar 3, 2026Jefferies

Jefferies Reiterates Hold Rating on Moderna (MRNA): "cash breakeven guidance is clearer"

Target:$37.00

-25.7%from $49.83

Feb 17, 2026RBC Capital

Moderna price target raised to $30 from $25 at RBC Capital

Target:$30.00

-29.5%from $42.54

Feb 17, 2026Evercore ISI

Moderna price target raised to $35 from $28 at Evercore ISI

Target:$35.00

-19.0%from $43.19

Feb 17, 2026Bernstein

Moderna price target raised to $45 from $35 at Bernstein

Target:$45.00

+6.6%from $42.23

Feb 16, 2026UBS

Moderna price target raised to $36 from $34 at UBS

Target:$36.00

-14.8%from $42.23

Feb 16, 2026Morgan Stanley

Moderna price target raised to $30 from $28 at Morgan Stanley

Target:$30.00

-29.0%from $42.23

Jan 6, 2026UBS

Moderna assumed at Neutral from Buy at UBS

Target:$34.00

-4.7%from $35.66

Dec 12, 2025Morgan Stanley

Moderna price target lowered to $28 from $30 at Morgan Stanley

Target:$28.00

-6.4%from $29.90

Dec 12, 2025Jefferies

Moderna initiated with a Hold at Jefferies

Target:$30.00

+1.3%from $29.62

Nov 21, 2025RBC Capital

Moderna price target lowered to $25 from $28 at RBC Capital

Target:$25.00

+8.2%from $23.10

Nov 21, 2025UBS

Moderna price target raised to $18 from $15 at Leerink

Target:$18.00

-19.5%from $22.36

Nov 21, 2025Piper Sandler

Moderna price target lowered to $63 from $69 at Piper Sandler

Target:$63.00

+181.8%from $22.36

Nov 20, 2025Wolfe Research

Moderna price target raised to $17 from $16 at Wolfe Research

Target:$17.00

-24.0%from $22.36

Nov 17, 2025Berenberg Bank

Moderna price target lowered to $28 from $30 at Berenberg

Target:$28.00

+13.0%from $24.77

Oct 23, 2025UBS

Moderna price target lowered to $40 from $70 at UBS

Target:$40.00

+49.0%from $26.85

Aug 22, 2025Leerink Partners

Moderna price target lowered to $15 from $18 at Leerink

Target:$15.00

-44.7%from $27.12

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance